ArticleCardiovascular diabetology2016

Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.

Sherin Bakhashab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.